Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease

NCT04394117 is registered in ClinicalTrials.gov with The George Institute as lead sponsor.

NCT NCT04394117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04394117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease
Lead sponsor
The George Institute
Phase
Phase 4
Overall status
Completed
Start date
June 19, 2020
Completion date
January 17, 2022
Enrollment
787 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus disease 2019, covid-19